<DOC>
	<DOC>NCT00233532</DOC>
	<brief_summary>The TRAIL study was conducted to examine the effects of escalating doses of an ACE inhibitor, trandolapril, on lowering blood pressure in Stage 1-2 hypertensive patients.</brief_summary>
	<brief_title>Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Trandolapril</mesh_term>
	<criteria>Stage 1 or 2 Hypertension Uncontrolled diabetes Subject has a hypersensitivity to ACE inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Trandolapril</keyword>
</DOC>